Carl Icahn on Activist Investing
Carl Icahn speaks at the Active-Passive Summit about Apple’s valuation, his plan to back new activist investors and the capital required to enter the field. He defends activism against Marty Lipton’s criticism, discusses Bill Ackman and Valeant’s Allergan bid, argues that early poison pills weaken shareholder accountability, and says Icahn Enterprises remains undervalued over the long term.
Passages
0:48 “I hope it’s going to report, but I think it’s very undervalued. I mean, as a long term hold, I, I think they spent billions, billions in research development.” Share
Search what Icahn said from Claude, ChatGPT or your own code. See plans